Back
ESC Premium Access

Primary prevention of sudden cardiac death in patients with tetralogy of Fallot with implantable cardioverter defibrillator: insights from the DAI-T4F study

Session: Prognosis, identification & treatment of ventricular arrhythmia
Topic: Device Treatment
Speaker: Doctor V. Waldmann (Paris, FR)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Victor Waldmann

European Georges Pompidou Hospital, Paris (France)
3 presentations
0 follower

9 more presentations in this session

Incidental Ventricular Tachycardia: Short and Long-term Prognosis

Speaker: Doctor A. Sajadieh (Copenhagen, DK)

Access
Abstract
Slides
Video
Thumbnail

Intra-cardiac thrombus in patients undergoing ventricular tachycardia ablation. a computed tomographic scan study

Speaker: Professor F. Sacher (Bordeaux, FR)

Access
Abstract
Slides
Video
Thumbnail

Zero- or near-zero-fluoroscopy radiofrequency catheter ablation for aortic sinus cusp idiopathic ventricular arrhythmias

Speaker: Associate Professor S. Stec (Przemysl, PL)

Access
Abstract
Slides
Video
Thumbnail

Ablation of scar-related ventricular tachycardia: paced electrogram feature analysis (PEFA) is a novel and effective substrate based strategy

Speaker: Doctor D. Crinion (Dublin, IE)

Access
Abstract
Slides
Video
Thumbnail

Electrocardiographic predictors of appropriate implantable cardioverter defibrillator therapies in patients with tetralogy of Fallot

Speaker: Doctor G. Duthoit (Paris, FR)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Prognosis, identification & treatment of ventricular arrhythmia

Speakers: Doctor V. Waldmann, Doctor A. Sajadieh, Professor F. Sacher, Associate Professor S. Stec, Doctor D. Crinion...
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb